HistoWiz automates histopathology with rapid turnaround time for researchers in academia, biotech and pharma. The company processes tissue specimens and digitizes the results, hosting client's data on a proprietary platform, PathologyMapTM. This online platform contains the largest collection of preclinical pathology data crowdsourced from the scientific community and the first network of top pathologists for on-demand diagnosis. Through automation and AI, HistoWiz aims to become the global leader in histopathology to accelerate cancer research and drug discovery.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 10/19/21 | $32,000,000 | Series A |
Asahi Kasai Ventures Jon Oringer VenBio Vivo Capital  | undisclosed |
